Genzyme buys cancer specialists Bioenvision

May 31, 2007
Research and Development

Genzyme is to spend $345 million on acquiring specialist pharma company Bioenvision and its oncology portfolio.Genzyme already co-markets with Bioenvision …

Avandia safety concerns hit GSK shares

May 31, 2007
Sales and Marketing

Shares in GSK have taken another hit after news that US prescribers have turned away from diabetes drug Avandia in …

Product roundup from Datamonitor

May 29, 2007
Sales and Marketing

ADHD drug as effective in boys as girls, says ShireUK pharmaceutical company Shire has said that results from a study …

Industry outlines concerns with NICE to Parliament

May 24, 2007

NICE's shortfalls have compromised public confidence in the cost and clinical-effectiveness body, the pharmaceutical industry has told MPs.The comments were …

PCTs ‘overspending’ on prescribing

May 24, 2007

PCTs could save the NHS more than £200 million if they can persuade more GPs to prescribe generically, according to …

Report raises safety concerns over Avandia

May 24, 2007
Sales and Marketing

GlaxoSmithKline has been forced on the defensive after its blockbuster diabetes treatment Avandia was linked to an increased risk of …

The Changing Face of Medical Education

May 23, 2007
Medical Communications, Sales and Marketing medical education

Is Medical Education the new PR?Phil Sheldon, Managing Director, Resolute Communications:Clients are increasingly waking up to the fact that medical …

Charity outlines vision for tackling cancer

May 23, 2007
Sales and Marketing

Cancer Research UK has set out an ambitious list of goals to reach by 2020, which it hopes will inspire …

Pfizer loses heads of research and finance

May 23, 2007
Research and Development, Sales and Marketing

Two key Pfizer executives are to step down as the company continues its drive to reinvigorate itself.The departures follow the …

Edelman scoops European Viagra account

May 23, 2007
Medical Communications

Pfizer has appointed PR agency Edelman to raise the European profile of its blockbuster erectile dysfunction treatment, Viagra.The company has …

Latest news from Datamonitor

May 23, 2007
Sales and Marketing

Breast cancer patients may be offered chemo-free treatmentHormone therapy drugs such as AstraZeneca's Zoladex may be as effective as traditional …

Med Ed comes of age

May 17, 2007
Medical Communications, Sales and Marketing medical education

Even a casual observer will have noticed the large contribution pharma makes to postgraduate medical education, both in the UK …

Roche selects Ketchum for pandemic work

May 17, 2007
Medical Communications

PR agency Ketchum has scooped a global account for Tamiflu as Roche begins further research into its use against bird …

Clinical news from Datamonitor

May 17, 2007
Research and Development

FDA requests additional efficacy data for Dendreon's Provenge in advanced prostate cancer.Dendreon has received a complete response letter from the …

Pharma news from Datamonitor

May 17, 2007
Sales and Marketing

Meda and Ethypharm collaborate on NSAIDMeda and Ethypharm have signed an exclusive 15-year agreement for an innovative NSAID product which …

NICE blocks Erbitux for head and neck cancer

May 17, 2007

Merck's targeted cancer drug Erbitux has been rejected by NICE for use against head and neck cancer.The Watchdog's Final Appraisal …

Gates Foundation could rival pharma, analysts warn

May 15, 2007
Sales and Marketing Gates Foundation, HIV, TB, vaccines

 The pharmaceutical industry could suffer a blow to its reputation, and could even suffer commercially, if it fails to appreciate …

GP prescribing costs contained in ’06

May 15, 2007
Sales and Marketing

Pharma revenues from primary care prescribing in England edged up three per cent in 2006, with fewer GP-led product launches …

‘Research must be nurtured,’ says industry

May 15, 2007
Research and Development

Nearly 1,000 potential future medicines are in the pipelines of some 50 companies operating in the UK, a survey by …

Date for NICE court showdown announced

May 14, 2007
Sales and Marketing

NICE's decision to block access to Alzheimer's drugs will be put under legal scrutiny on 25 June when a much …

The Gateway to Local Adoption Series

Latest content